BR9914547A - Sistema de fornecimento para somatotropina de suìno - Google Patents

Sistema de fornecimento para somatotropina de suìno

Info

Publication number
BR9914547A
BR9914547A BR9914547-2A BR9914547A BR9914547A BR 9914547 A BR9914547 A BR 9914547A BR 9914547 A BR9914547 A BR 9914547A BR 9914547 A BR9914547 A BR 9914547A
Authority
BR
Brazil
Prior art keywords
host
supply system
somatotropin
expression construct
semipermeable membrane
Prior art date
Application number
BR9914547-2A
Other languages
English (en)
Inventor
Mitchell Keegan
Mark Richard Jones
Geoffrey Philip M Moore
Original Assignee
Commw Scient Ind Res Org
Univ Western Sydney Nepean
Pig Res And Dev Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commw Scient Ind Res Org, Univ Western Sydney Nepean, Pig Res And Dev Corp filed Critical Commw Scient Ind Res Org
Publication of BR9914547A publication Critical patent/BR9914547A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

<B>SISTEMA DE FORNECIMENTO PARA SOMATOTROPINA DE SUìNO<D> é revelada uma construção de expressão que é útil para fornecer um polipeptídeo exógeno (por exemplo, um hormónio de crescimento como somatotropina) a um hospedeiro. Em uma aplicação da invenção, a construção de expressão é introduzida em uma célula recombinante não hospedeira encapsulada em uma membrana semipermeável para implantação no hospedeiro. A membrana semipermeável inibe eventos de rejeição de célula e vigilância imune de modo que células recombinantes altamente em expressão, não hospedeiros possam ser utilizados.
BR9914547-2A 1998-10-16 1999-10-18 Sistema de fornecimento para somatotropina de suìno BR9914547A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP6556A AUPP655698A0 (en) 1998-10-16 1998-10-16 Delivery system for porcine somatotropin
PCT/AU1999/000896 WO2000023601A1 (en) 1998-10-16 1999-10-18 Delivery system for porcine somatotropin

Publications (1)

Publication Number Publication Date
BR9914547A true BR9914547A (pt) 2001-06-26

Family

ID=3810777

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9914547-2A BR9914547A (pt) 1998-10-16 1999-10-18 Sistema de fornecimento para somatotropina de suìno

Country Status (14)

Country Link
US (2) US6967089B1 (pt)
EP (1) EP1121449A4 (pt)
JP (1) JP2002527112A (pt)
KR (1) KR20010099687A (pt)
CN (1) CN1325650C (pt)
AU (1) AUPP655698A0 (pt)
BR (1) BR9914547A (pt)
CA (1) CA2346799A1 (pt)
ID (1) ID30149A (pt)
MX (1) MXPA01003810A (pt)
NZ (1) NZ510943A (pt)
RU (1) RU2268940C2 (pt)
WO (1) WO2000023601A1 (pt)
ZA (1) ZA200102965B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP655698A0 (en) * 1998-10-16 1998-11-05 Commonwealth Scientific And Industrial Research Organisation Delivery system for porcine somatotropin
EP4154914A1 (en) * 2015-05-07 2023-03-29 University of South Florida Modified ube3a gene for a gene therapy approach for angelman syndrome
WO2019147623A2 (en) * 2018-01-23 2019-08-01 Virginia Commonwealth University Mda-7/il secretory variants and methods of use
CN109929849B (zh) * 2019-03-18 2021-05-04 华南农业大学 一种优化的pGH基因、蛋白及在提高毕赤酵母分泌表达pGH产量和活性中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR70279B (pt) * 1979-09-12 1982-09-03 Univ California
US4923808A (en) 1985-03-12 1990-05-08 Genentech, Inc. Method for identifying mutants secreting high levels of heterologous proteins
GB8529014D0 (en) * 1985-11-25 1986-01-02 Biogen Nv Enhanced secretion of heterologous proteins
US4992367A (en) * 1986-05-12 1991-02-12 Hoffmann-La Roche Inc. Enhanced expression of human interleukin-2 in mammalian cells
US5200509A (en) * 1987-04-06 1993-04-06 Celtrix Pharmaceuticals, Inc. Human somatomedin carrier protein subunits and process for producing them; recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
US5681562A (en) 1991-06-25 1997-10-28 Sidney Kimmel Cancer Center Lymphokine gene therapy of cancer
US5932211A (en) 1991-11-12 1999-08-03 Women's And Children's Hospital Glycosylation variants of iduronate 2-sulfatase
US5545423A (en) 1991-11-25 1996-08-13 Vivorx, Inc. Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials
US5858751A (en) * 1992-03-09 1999-01-12 The Regents Of The University Of California Compositions and methods for producing sialyltransferases
US5641665A (en) 1994-11-28 1997-06-24 Vical Incorporated Plasmids suitable for IL-2 expression
GB9526733D0 (en) * 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
US5856159A (en) 1996-03-27 1999-01-05 Cytel Corporation Production of galactosyltransferase
WO2000014216A1 (en) * 1998-09-04 2000-03-16 Zk Pharmaceuticals, Inc. Method for selecting peptides inhibiting viral surface protein binding to cell surface receptor
AUPP655698A0 (en) * 1998-10-16 1998-11-05 Commonwealth Scientific And Industrial Research Organisation Delivery system for porcine somatotropin
US20040053276A1 (en) * 2000-09-22 2004-03-18 Yasuaki Ito Novel tissue-specific secretory polypeptide and dna thereof
EP1360964A4 (en) * 2001-01-19 2004-03-31 Takeda Chemical Industries Ltd USE OF A GALANINE-LIKE PEPTID
US6811785B2 (en) * 2001-05-07 2004-11-02 Mount Sinai School Of Medicine Of New York University Multivalent MHC class II—peptide chimeras

Also Published As

Publication number Publication date
CN1325650C (zh) 2007-07-11
AUPP655698A0 (en) 1998-11-05
EP1121449A4 (en) 2004-12-01
US20060062772A1 (en) 2006-03-23
CA2346799A1 (en) 2000-04-27
NZ510943A (en) 2004-10-29
ID30149A (id) 2001-11-08
CN1323348A (zh) 2001-11-21
WO2000023601A1 (en) 2000-04-27
EP1121449A1 (en) 2001-08-08
MXPA01003810A (es) 2003-10-14
JP2002527112A (ja) 2002-08-27
KR20010099687A (ko) 2001-11-09
RU2268940C2 (ru) 2006-01-27
US6967089B1 (en) 2005-11-22
ZA200102965B (en) 2001-10-12

Similar Documents

Publication Publication Date Title
US4767628B1 (pt)
LU90806I2 (fr) Ovidrelle-choriogonadotropine alfa et ses d-riv-s pharmaceutiquement acceptables
DE69021335T2 (de) Wachstumshormonfusionsproteine.
Schally et al. Evidence for peptide nature of LH and FSH-releasing hormones
KR910007542A (ko) 폴리펩타이드의 서방형 조성물
NO941186L (no) Hormonanaloger med multiple CTP-forlengelser
Morrissey et al. The secretion of parathormone fragments 34–84 and 37–84 by dispersed porcine parathyroid cells
ATE86128T1 (de) Gewebeimplantat.
BRPI0412799A (pt) imunógeno, composição, ácido nucleico, célula recombinante, métodos para preparar um polipeptìdeo, para induzir um a resposta imune protetora em um paciente e para induzir uma resposta anamnésica em um paciente, e, seqüência de ácido nucleico otimizada de levedura
AU5385486A (en) Biologically active protein compositions and a method of use
BR9713108A (pt) Colagenase recombinante do tipo i de clostridium histolytucum e o uso da mesma para o isolamento de células e de grupos de células
ATE81135T1 (de) Aktive thymopentin-analoga.
ATE246247T1 (de) Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
ATE239225T1 (de) Injektion durch elektromigration von einer mikroreservoir elektrode in ein kapillares separationssystem
AR012499A1 (es) Una secuencia quimerica de acido nucleico que codifica una proteina de fusion, un vector de expresion que comprende dicha secuencia quimerica, una celula huesped transformada que contiene dicho vector, la proteina de fusion obtenida y un metodo in vitro para la preparacion de un polipeptido recombin
BR9914547A (pt) Sistema de fornecimento para somatotropina de suìno
PT1621633E (pt) Glicoproteínas produzidas em plantas com supressão da expressão de beta 1,2-xilosiltransferase
ES2053635T3 (es) Metodo para la preparacion de la hormona humana del crecimiento.
ATE374246T1 (de) Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter
ES8605296A1 (es) Procedimiento de producir factor viii-r humano
MXPA01011158A (es) Factor de crecimiento homologo zvegf4.
ES2122921B1 (es) Proteinas recombinantes de fusion del virus reproductivo y respiratorio porcino (prrsv) y su empleo en diagnostico.
MY103759A (en) Biologically active molecules
DK0467839T3 (da) In-vitro-behandling af fusionsproteiner
ES2033212A6 (es) Procedimiento para la obtencion de peptidos puramente glicosilados, parcialmente glicosilados o no glicosilados.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 10 (VIII) DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.